Fox Chase Cancer Center Welcomes Lilian Shin-Cho

Dr. Shin-cho
Fox Chase Cancer Center is pleased to announce the hiring of Lilian Shin-Cho, PhD, as an Assistant Professor in the Cancer Prevention and Control Research Program.

PHILADELPHIA (February 15, 2024) — Fox Chase Cancer Center is pleased to announce the hiring of Lilian Shin-Cho, PhD, as an Assistant Professor in the Cancer Prevention and Control Research Program.

Prior to joining Fox Chase, Shin-Cho was a postdoctoral fellow at the University of Texas MD Anderson Cancer Center in Houston, where she was a member of the Cancer Prevention Research Training Program and received the 2023 Outstanding Postdoctoral Fellow in Cancer Prevention Award.

During her fellowship, Shin-Cho worked on research projects related to psychological well-being in cancer patients who are members of collectivist cultures, which emphasize the needs and goals of the group in addition to those of the individual. She also focused on designing positive activity interventions for Asian American cancer patients and caregivers.

Shin-Cho earned her undergraduate degree from Northwestern University. She earned a master’s and a doctoral degree in psychology from the University of California, Riverside.

Over the course of her career, Shin-Cho has authored multiple peer-reviewed articles in journals such as Psycho-Oncology and The Journal of Positive Psychology and has presented her research at national behavioral medicine conferences.

Shin-Cho is the principal investigator of an NIH/NCI Early Stage K99/R00 Pathway to Independence Award grant for outstanding early-stage postdoctoral researchers pursuing a career in cancer control science.

She is a member of the Society of Behavioral Medicine, the Association for Psychological Science, and the Society for Personality and Social Psychology.

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence six consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

For more information, call 888-369-2427